Interestingly, one recent study published in Blood reported a distinct single-cell T-cell signature associated with stem cell transplantation outcome in AML patients; one of the included genes was GPR56, a biomarker of alloreactive CD8+ T cells (55). Here, CD8A is linked to acute myeloid leukemia.